StemCells (STEM) Misses Q3 EPS by 2c
Tweet
Share
E-mailGet Alerts STEM Hot Sheet
Price: $6.09 +11.74%
Financial Fact:
Total operating expenses: 8.91M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Total operating expenses: 8.91M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
StemCells (NASDAQ: STEM) reported Q3 EPS of ($0.14), $0.02 worse than the analyst estimate of ($0.12). Revenue for the quarter came in at $883 million versus the consensus estimate of $220 million.
For earnings history and earnings-related data on StemCells (STEM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies sees a buying opportunity in this S&P 500 sector
- Azitra, Inc. (AZTR) Tops Q2 EPS by 54c
- Wolfe Research upgrades Biogen, AbbVie on pipeline strength and valuation
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
